Phyllis I. Warkentin

2.8k total citations · 1 hit paper
55 papers, 2.1k citations indexed

About

Phyllis I. Warkentin is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Phyllis I. Warkentin has authored 55 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 12 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Phyllis I. Warkentin's work include Hematopoietic Stem Cell Transplantation (23 papers), Virus-based gene therapy research (5 papers) and Acute Myeloid Leukemia Research (5 papers). Phyllis I. Warkentin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (23 papers), Virus-based gene therapy research (5 papers) and Acute Myeloid Leukemia Research (5 papers). Phyllis I. Warkentin collaborates with scholars based in United States, India and Belgium. Phyllis I. Warkentin's co-authors include Stephen C. Strom, Timothy C. Goertzen, Ira J. Fox, Kenneth Dorko, Bernhard Sauter, Jayanta Roy Chowdhury, Stuart S. Kaufman, Namita Roy Chowdhury, John H. Kersey and Norma K.C. Ramsay and has published in prestigious journals such as New England Journal of Medicine, Blood and The Journal of Immunology.

In The Last Decade

Phyllis I. Warkentin

54 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation

1998 775 citations Phyllis I. Warkentin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phyllis I. Warkentin United States	17	896	712	503	399	361	55	2.1k
Nils Kinnman Sweden	19	405 0.5×	809 1.1×	277 0.6×	203 0.5×	351 1.0×	33	2.0k
Frank S. Fan Taiwan	20	366 0.4×	194 0.3×	256 0.5×	217 0.5×	358 1.0×	84	1.4k
Takeshi Nagao Japan	16	419 0.5×	639 0.9×	184 0.4×	149 0.4×	241 0.7×	64	1.3k
Pietro Muretto Italy	27	297 0.3×	190 0.3×	528 1.0×	1.1k 2.8×	634 1.8×	77	2.8k
Randall G. Lee United States	24	1.3k 1.4×	660 0.9×	132 0.3×	132 0.3×	380 1.1×	41	2.6k
Masahiro Ohira Japan	22	491 0.5×	502 0.7×	415 0.8×	175 0.4×	572 1.6×	185	2.0k
Kathelijne Peerlinck Belgium	32	389 0.4×	217 0.3×	459 0.9×	2.5k 6.2×	155 0.4×	133	3.5k
Attaphol Pawarode United States	17	297 0.3×	342 0.5×	135 0.3×	459 1.2×	244 0.7×	64	1.1k
J R Goepel United Kingdom	22	554 0.6×	357 0.5×	435 0.9×	32 0.1×	388 1.1×	65	1.7k
SI Bearman United States	17	181 0.2×	122 0.2×	392 0.8×	1.4k 3.4×	509 1.4×	35	2.3k

Countries citing papers authored by Phyllis I. Warkentin

Since Specialization

Citations

This map shows the geographic impact of Phyllis I. Warkentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis I. Warkentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis I. Warkentin more than expected).

Fields of papers citing papers by Phyllis I. Warkentin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phyllis I. Warkentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis I. Warkentin. The network helps show where Phyllis I. Warkentin may publish in the future.

Co-authorship network of co-authors of Phyllis I. Warkentin

This figure shows the co-authorship network connecting the top 25 collaborators of Phyllis I. Warkentin. A scholar is included among the top collaborators of Phyllis I. Warkentin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phyllis I. Warkentin. Phyllis I. Warkentin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carpenter, Paul A. & Phyllis I. Warkentin. (2025). Improving Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy: Evolution of ASTCT Practice Guidelines and FACT Inspections. Transplantation and Cellular Therapy. 31(11). 843–848.

McNiece, Ian, et al.. (2021). Standardization, workforce development and advocacy in cell and gene therapies: a summary of the 2020 Regenerative Medicine InterCHANGE. Cytotherapy. 23(10). 886–893. 6 indexed citations

LeMaistre, Charles F., Luke P. Akard, Dennis A. Gastineau, et al.. (2019). Integration of Publicly Reported Center Outcomes into Standards and Accreditation: The FACT Model. Biology of Blood and Marrow Transplantation. 25(11). 2243–2250. 4 indexed citations

Gümüşçü, Burak, et al.. (2013). Successful Unrelated Cord Blood Transplantation For Homozygous α-Thalassemia. Journal of Pediatric Hematology/Oncology. 35(7). 570–572. 8 indexed citations

Gülen, Dumrul, et al.. (2012). Cryopreservation of adenovirus-transfected dendritic cells (DCs) for clinical use. International Immunopharmacology. 13(1). 61–68. 8 indexed citations

Gülen, Dumrul, Fuminori Abe, Sarah A. Maas, et al.. (2008). Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors. International Immunopharmacology. 8(13-14). 1728–1736. 14 indexed citations

Ashford, Paul, Adrian P. Gee, Stella Larsson, et al.. (2007). Standards for the Terminology and Labeling of Cellular Therapy Products. Transfusion. 47(7). 1319–1327. 7 indexed citations

Ashford, Paul, Adrian P. Gee, Stella Larsson, et al.. (2007). Terminology and labeling of cellular products–2: Implementation plan. Bone Marrow Transplantation. 40(11). 1085–1090. 3 indexed citations

Warkentin, Phyllis I., et al.. (2000). FAHCT accreditation: common deficiencies during on-site inspections. Cytotherapy. 2(3). 213–220. 11 indexed citations

10.

Joshi, S. K., K B Miller, John D. Jackson, Phyllis I. Warkentin, & Anne Kessinger. (2000). Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients. Cytotherapy. 2(1). 15–24. 7 indexed citations

11.

Pirruccello, Samuel J., et al.. (1999). Comparison of ISHAGE protocol CD34 cell enumeration with a lineage negative backgating technique. Cytotherapy. 1(4). 279–286. 4 indexed citations

12.

Bishop, Michael, Jonathan Jackson, Stefano Tarantolo, et al.. (1997). Ex Vivo Treatment of Bone Marrow with Phosphorothioate Oligonucleotide OL(l)p53 for Autologous Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Journal of Hematotherapy. 6(5). 441–446. 20 indexed citations

13.

Feig, Stephen A., Matthew M. Ames, Harland N. Sather, et al.. (1996). Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group. Medical and Pediatric Oncology. 27(6). 505–514. 30 indexed citations

14.

Weide, Lamont G., et al.. (1994). Comparison of two microbiological culture techniques used to monitor islet cell isolation contamination.. PubMed. 26(6). 3439–40. 1 indexed citations

15.

Bierman, Philip J., Phyllis I. Warkentin, Mark Hutchins, & Lynell W. Klassen. (1993). Pure Red Cell Aplasia Following ABO Mismatched Marrow Transplantation for Chronic Lymphocytic Leukemia: Response to Antithymocyte Globulin. Leukemia & lymphoma. 9(1-2). 169–171. 17 indexed citations

16.

Gordon, Bruce G., Dennis D. Weisenburger, Phyllis I. Warkentin, et al.. (1993). Peripheral T-cell lymphoma in childhood and adolescence a clinicopathologic study of 22 patients. Cancer. 71(1). 257–263. 38 indexed citations

17.

Gordon, Bruce G., et al.. (1991). Cerebral infarction associated with protein C deficiency following allogeneic bone marrow transplantation.. PubMed. 8(4). 323–5. 13 indexed citations

18.

Gordon, Bruce G., et al.. (1991). Successful Treatment of Severe Aplastic Anemia by Bone Marrow Transplantation from HLA Nonidentical Family Members. Journal of Pediatric Hematology/Oncology. 13(1). 29–33. 2 indexed citations

19.

Saarinen, Ulla M., et al.. (1987). DIFFERENTIATION OF PRESUMED SEPSIS FROM ACUTE GRAFT-VERSUS-HOST DISEASE BY C-REACTIVE PROTEIN AND SERUM TOTAL IgE IN BONE MARROW TRANSPLANT RECIPIENTS. Transplantation. 44(4). 540–546. 13 indexed citations

20.

Cheung, N K, Ulla M. Saarinen, J E Neely, et al.. (1985). Development of neuroblastoma monoclonal antibodies for potential utilization in diagnosis and therapy.. PubMed. 175. 501–5. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact